Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure.

Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's ...

Researchers also noticed that the mice used as models for Alzheimer’s disease who were given stool transplants from healthy ...

Merck follows in the footsteps of Bristol Myers Squibb, which in December 2023 also failed to secure a late-stage victory for ...

Colorectal cancer (CRC) is no laughing matter. It's the second-leading cause of cancer deaths globally, according to the ...

Merck & Co Inc (NYSE:MRK) released topline data from the KEYFORM-007 Phase 3 study of the fixed-dose combination of ...

Researchers sought to determine the effect of antibiotics on the risk of colorectal cancer recurrence after surgery.